These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 35550773)

  • 1. Chitosan nanocarriers for microRNA delivery and detection: A preliminary review with emphasis on cancer.
    Sargazi S; Siddiqui B; Qindeel M; Rahdar A; Bilal M; Behzadmehr R; Mirinejad S; Pandey S
    Carbohydr Polym; 2022 Aug; 290():119489. PubMed ID: 35550773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan-modified nanocarriers as carriers for anticancer drug delivery: Promises and hurdles.
    Alhodieb FS; Barkat MA; Barkat HA; Hadi HA; Khan MI; Ashfaq F; Rahman MA; Hassan MZ; Alanezi AA
    Int J Biol Macromol; 2022 Sep; 217():457-469. PubMed ID: 35798082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan Based MicroRNA Nanocarriers.
    Genedy HH; Delair T; Montembault A
    Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of MicroRNAs by Chitosan Nanoparticles to Functionally Alter Macrophage Cholesterol Efflux in Vitro and in Vivo.
    Nguyen MA; Wyatt H; Susser L; Geoffrion M; Rasheed A; Duchez AC; Cottee ML; Afolayan E; Farah E; Kahiel Z; Côté M; Gadde S; Rayner KJ
    ACS Nano; 2019 Jun; 13(6):6491-6505. PubMed ID: 31125197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of chitosan-based nanocarriers in tumor-targeted drug delivery.
    Ghaz-Jahanian MA; Abbaspour-Aghdam F; Anarjan N; Berenjian A; Jafarizadeh-Malmiri H
    Mol Biotechnol; 2015 Mar; 57(3):201-18. PubMed ID: 25385004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan - A Potential Polymer to Prepare Anticancer Drug Delivery Systems: Patent Review.
    Kriplani P; Guarve K
    Recent Pat Anticancer Drug Discov; 2021; 16(2):249-257. PubMed ID: 33563157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug and gene co-delivery systems for cancer treatment.
    Yang Z; Gao D; Cao Z; Zhang C; Cheng D; Liu J; Shuai X
    Biomater Sci; 2015 Jul; 3(7):1035-49. PubMed ID: 26221938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connecting the dots in drug delivery: A tour d'horizon of chitosan-based nanocarriers system.
    Pramanik S; Sali V
    Int J Biol Macromol; 2021 Feb; 169():103-121. PubMed ID: 33338522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-targeting glycol chitosan nanocarriers: overcoming the challenges posed by chemotherapeutics.
    Choi Y; Lim S; Yoon HY; Kim BS; Kwon IC; Kim K
    Expert Opin Drug Deliv; 2019 Aug; 16(8):835-846. PubMed ID: 31343904
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.
    Gandhi NS; Tekade RK; Chougule MB
    J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nano-Chitosan Particles in Anticancer Drug Delivery: An Up-to-Date Review.
    Kamath PR; Sunil D
    Mini Rev Med Chem; 2017; 17(15):1457-1487. PubMed ID: 28245780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-functional chitosan-based nanoparticles for drug delivery: Recent advanced insight into cancer therapy.
    Tian B; Hua S; Liu J
    Carbohydr Polym; 2023 Sep; 315():120972. PubMed ID: 37230614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytosolic co-delivery of miRNA-34a and docetaxel with core-shell nanocarriers via caveolae-mediated pathway for the treatment of metastatic breast cancer.
    Zhang L; Yang X; Lv Y; Xin X; Qin C; Han X; Yang L; He W; Yin L
    Sci Rep; 2017 Apr; 7():46186. PubMed ID: 28383524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Antimicrobial Applications of Chitosan Nanoparticles (ChNP).
    Rozman NAS; Tong WY; Leong CR; Tan WN; Hasanolbasori MA; Abdullah SZ
    J Microbiol Biotechnol; 2019 Jul; 29(7):1009-1013. PubMed ID: 31288302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in systemic co-delivery of microRNAs and chemotherapeutics for cancer treatment by using lipid-based nanoparticles.
    He W; Turkeshi A; Li X; Zhang H
    Ther Deliv; 2020 Sep; 11(9):591-603. PubMed ID: 32933403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eco-friendly chitosan-based nanostructures in diabetes mellitus therapy: Promising bioplatforms with versatile therapeutic perspectives.
    Taheriazam A; Entezari M; Firouz ZM; Hajimazdarany S; Hossein Heydargoy M; Amin Moghadassi AH; Moghadaci A; Sadrani A; Motahhary M; Harif Nashtifani A; Zabolian A; Tabari T; Hashemi M; Raesi R; Jiang M; Zhang X; Salimimoghadam S; Ertas YN; Sun D
    Environ Res; 2023 Jul; 228():115912. PubMed ID: 37068723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-viral nanocarriers for intracellular delivery of microRNA therapeutics.
    Bai Z; Wei J; Yu C; Han X; Qin X; Zhang C; Liao W; Li L; Huang W
    J Mater Chem B; 2019 Feb; 7(8):1209-1225. PubMed ID: 32255160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoscale delivery systems for microRNAs in cancer therapy.
    Boca S; Gulei D; Zimta AA; Onaciu A; Magdo L; Tigu AB; Ionescu C; Irimie A; Buiga R; Berindan-Neagoe I
    Cell Mol Life Sci; 2020 Mar; 77(6):1059-1086. PubMed ID: 31637450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates.
    Virmani T; Kumar G; Sharma A; Pathak K; Akhtar MS; Afzal O; Altamimi ASA
    Polymers (Basel); 2023 Jul; 15(13):. PubMed ID: 37447573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chitosan-Acrylic Polymeric Nanoparticles with Dynamic Covalent Bonds. Synthesis and Stimuli Behavior.
    Palacio H; Otálvaro F; Giraldo LF; Ponchel G; Segura-Sánchez F
    Chem Pharm Bull (Tokyo); 2017 Dec; 65(12):1132-1143. PubMed ID: 29021499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.